No company matches — see all tickers
Only filters 8-Ks. Other selected forms stay visible.
Develops Parkinson’s cell therapy from patients’ skin cells; IPO backs Phase 3 preparation, with more funding needed to finish trials.
No filings match these filters. Show all 8-K events
Request longer coverage
We read every message.
